Hematology/Oncology

Top Story

Close proximity to oil, gas development areas may increase risk for pediatric ALL

Close proximity to oil, gas development areas may increase risk for pediatric ALL
March 27, 2017

Young people living in Colorado diagnosed with acute lymphocytic leukemia were more likely to live in areas with a high-density of oil and gas development, according to study results.

This suggests that people living in these areas may have an increased risk for cancer, researchers wrote.

In the Journals Plus

Imatinib confers long-term survival in patients with gastrointestinal stromal tumors

March 27, 2017
Imatinib treatment conferred a “durable, long-term” OS in nearly a quarter of patients with metastatic gastrointestinal stromal tumors, or GIST, according

University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality

March 27, 2017
The University of Michigan has opened a center designed to provide individualized, structured care for men with a genetic predisposition to prostate cancer. The Prostate…
Meeting News

Nivolumab, pembrolizumab exhibit different toxicity profiles as melanoma monotherapy

March 27, 2017
NEW YORK — Nivolumab and pembrolizumab exhibited different toxicity profiles and appeared associated with different adverse event frequencies when used as…
Meeting NewsVideo

VIDEO: Highlights from the 2017 HemOnc Today Melanoma and Cutaneous Malignancies meeting

March 26, 2017
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of hematology and oncology at St. Luke’s Cancer…
More News Headlines »
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News

VIDEO: Guidelines on using relative risks for skin cancer screenings

March 14, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME CNE CPE

Individualized Prophylaxis in Hemophilia

Support for this activity has been made possible through an educational grant from Bayer HealthCare Pharmaceuticals

This program will provide education for hematologists, nurses, pharmacists, and other healthcare providers involved in…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement